These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27412451)

  • 1. Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.
    Doe-Simkins M; Banta-Green C; Davis CS; Green TC; Walley AY
    Addiction; 2016 Oct; 111(10):1879-80. PubMed ID: 27412451
    [No Abstract]   [Full Text] [Related]  

  • 2. While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.
    Coffin P; Rich J; Dailey M; Stancliff S; Beletsky L
    Addiction; 2016 Oct; 111(10):1880-1. PubMed ID: 27412566
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
    Strang J; McDonald R; Tas B; Day E
    Addiction; 2016 Apr; 111(4):574-82. PubMed ID: 26840916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letters to Addiction from Coffin et al. and Doe-Simpkins et al. re: 'For Debate' on clinical use of improvised nasal naloxone sprays: authors' response.
    Strang J; McDonald R
    Addiction; 2016 Oct; 111(10):1881-3. PubMed ID: 27412695
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 6. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approved nasal naloxone welcome, but unlicensed improvised naloxone spray kits remain a concern: proper scientific study must accompany innovation.
    Strang J; Mcdonald R
    Addiction; 2016 Apr; 111(4):590-2. PubMed ID: 26995172
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous use of intranasal naloxone: A case of overdose reversal.
    Das S; Shah N; Ghadiali M
    Subst Abus; 2017; 38(1):18-21. PubMed ID: 27925864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on Darke & Duflou (2016): Heroin-related deaths-identifying a window for intervention.
    Tas B; McDonald R
    Addiction; 2016 Sep; 111(9):1614-5. PubMed ID: 27516398
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
    Mundin G; McDonald R; Smith K; Harris S; Strang J
    Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Is nebulised naloxone effective in opioid overdose?
    Ishiyama D; Jones J
    Emerg Med J; 2013 Oct; 30(10):860. PubMed ID: 24014692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin and pharmaceutical opioid overdose events: Emergency medical response characteristics.
    Banta-Green CJ; Coffin PO; Schoeppe JA; Merrill JO; Whiteside LK; Ebersol AK
    Drug Alcohol Depend; 2017 Sep; 178():1-6. PubMed ID: 28623805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prevention and treatment strategies can help address the overdose crisis.
    Walley AY
    Prev Med; 2015 Nov; 80():37-40. PubMed ID: 25895840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.
    Neale J; Strang J
    Addiction; 2015 Oct; 110(10):1644-52. PubMed ID: 26119038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort.
    Kobayashi L; Green TC; Bowman SE; Ray MC; McKenzie MS; Rich JD
    Simul Healthc; 2017 Feb; 12(1):22-27. PubMed ID: 28146450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.